Inhibition of platelet aggregation by 2-(p-chlorophenyl)-4-thiazoleacrylic acid (Wy-23,049)--comparison with acetylsalicylic acid.
D000179:Acrylates / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects; D002722:Chlorobenzenes / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008239:Lysine / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011108:Polymers / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013844:Thiazoles / Q000494:pharmacology*; D013997:Time Factors
D000179:Acrylates; D002722:Chlorobenzenes; D011108:Polymers; D011453:Prostaglandins; D013844:Thiazoles; C006282:Wy 23049; D000244:Adenosine Diphosphate; D003094:Collagen; D000242:Cyclic AMP; D008239:Lysine; D001241:Aspirin; D007213:Indomethacin